BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 26068630)

  • 1. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
    Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
    Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
    Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
    J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
    Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
    Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction.
    Mertens S; Zeegers AG; Wertheimer PA; Hendriksz TR; van Bommel EF
    Int J Urol; 2014 Mar; 21(3):283-8. PubMed ID: 24033464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
    ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
    BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of full-length metallic stents in malignant ureteral obstruction.
    Abbasi A; Wyre HW; Ogan K
    J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of metallic stents for malignant ureteral obstruction.
    Goldsmith ZG; Wang AJ; BaƱez LL; Lipkin ME; Ferrandino MN; Preminger GM; Inman BA
    J Urol; 2012 Sep; 188(3):851-5. PubMed ID: 22819410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
    Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
    Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-institution experience with metallic ureteral stents: a cost-effective method of managing deficiencies in ureteral drainage.
    Baumgarten AS; Hakky TS; Carrion RE; Lockhart JL; Spiess PE
    Int Braz J Urol; 2014; 40(2):225-31. PubMed ID: 24856490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the success of retrograde stenting for managing ureteral obstruction.
    Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
    J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience with full-length metal stent to relieve malignant ureteral obstruction.
    Borin JF; Melamud O; Clayman RV
    J Endourol; 2006 May; 20(5):300-4. PubMed ID: 16724898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction.
    Modi AP; Ritch CR; Arend D; Walsh RM; Ordonez M; Landman J; Gupta M; Knudsen BE
    J Endourol; 2010 Jul; 24(7):1189-93. PubMed ID: 20575695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
    Song Y; Fei X; Song Y
    Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
    Kim M; Hong B; Park HK
    J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Matsuura H; Arase S; Hori Y
    Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents.
    Chow PM; Chiang IN; Chen CY; Huang KH; Hsu JS; Wang SM; Lee YJ; Yu HJ; Pu YS; Huang CY
    PLoS One; 2015; 10(8):e0135566. PubMed ID: 26267140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.